Cargando…

IgA-Biome Profiles Correlate with Clinical Parkinson’s Disease Subtypes

BACKGROUND: Parkinson’s disease is a heterogeneous neurodegenerative disorder with distinctive gut microbiome patterns suggesting that interventions targeting the gut microbiota may prevent, slow, or reverse disease progression and severity. OBJECTIVE: Because secretory IgA (SIgA) plays a key role i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Eric L., Essigmann, Heather T., Hoffman, Kristi L., Alexander, Ashley S., Newmark, Michael, Jiang, Zhi-Dong, Suescun, Jessika, Schiess, Mya C., Hanis, Craig L., DuPont, Herbert L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357173/ https://www.ncbi.nlm.nih.gov/pubmed/37212075 http://dx.doi.org/10.3233/JPD-230066

Ejemplares similares

The impact of the Th17:Treg axis on the IgA-Biome across the glycemic spectrum
por: Essigmann, Heather T., et al.
Publicado: (2021)

Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study
por: DuPont, Herbert L., et al.
Publicado: (2023)

Earlier Intervention with Deep Brain Stimulation for Parkinson's Disease
por: Suarez-Cedeno, Gerson, et al.
Publicado: (2017)

Computational medication regimen for Parkinson’s disease using reinforcement learning
por: Kim, Yejin, et al.
Publicado: (2021)

Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levels
por: Adams, Christopher, et al.
Publicado: (2023)

A Study of the Relationship Between Uric Acid and Substantia Nigra Brain Connectivity in Patients With REM Sleep Behavior Disorder and Parkinson's Disease
por: Ellmore, Timothy M., et al.
Publicado: (2020)

Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation
por: DuPont, Herbert L., et al.
Publicado: (2022)

Longitudinal Connectomes as a Candidate Progression Marker for Prodromal Parkinson’s Disease
por: Peña-Nogales, Óscar, et al.
Publicado: (2019)

Toward a Multimodal Computer-Aided Diagnostic Tool for Alzheimer’s Disease Conversion
por: Pena, Danilo, et al.
Publicado: (2022)

Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease
por: Schiess, Mya, et al.
Publicado: (2021)

Quantifying Neurodegenerative Progression With DeepSymNet, an End-to-End Data-Driven Approach
por: Pena, Danilo, et al.
Publicado: (2019)

Salivary IgA subtypes as novel disease biomarkers in systemic lupus erythematosus
por: Romero-Ramírez, Sandra, et al.
Publicado: (2023)

Transient IgA, steady IgG?
por: Berthold, Dorothée L., et al.
Publicado: (2020)

Slowed Prosaccades and Increased Antisaccade Errors As a Potential Behavioral Biomarker of Multiple System Atrophy
por: Brooks, Sarah H., et al.
Publicado: (2017)

Recombinant IgA Antibodies
por: Yoo, Esther M., et al.
Publicado: (2007)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

IgA Vasculitis Following COVID-19 Vaccination
por: Rista, Elvana, et al.
Publicado: (2023)

Case Presentation – IgA Nephropathy
por: Williams, David L.
Publicado: (2005)

Targeted Transcriptional Analysis of IgA Vasculitis, IgA Nephropathy, and IgA-Dominant Infection-Related Glomerulonephritis Reveals Both Distinct and Overlapping Immune Signatures
por: Kung, Vanderlene L., et al.
Publicado: (2023)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Proteomic profiling of IgA nephropathy reveals distinct molecular prognostic subtypes
por: Chen, Xizhao, et al.
Publicado: (2023)

The inflammatory function of human IgA
por: Hansen, Ivo S., et al.
Publicado: (2018)

Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum
por: Sánchez-Salguero, Erick, et al.
Publicado: (2019)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

IgA Staining Patterns Differentiate Between IgA Nephropathy and IgA-Dominant Infection-Associated Glomerulonephritis
por: Brodsky, Sergey V., et al.
Publicado: (2020)

Increased Urinary IgA in Paediatric IgA Vasculitis Nephritis
por: Marro, Julien, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

CSF from Parkinson disease Patients Differentially Affects Cultured Microglia and Astrocytes
por: Schiess, Mya C, et al.
Publicado: (2010)

The effect of single biome occupancy on the estimation of biome shifts and the detection of biome conservatism
por: Dale, Esther E., et al.
Publicado: (2021)

The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin
por: Bohländer, Fabian, et al.
Publicado: (2021)

Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota
por: Goedert, James J, et al.
Publicado: (2018)

Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells
por: Reterink, T. J. F., et al.
Publicado: (1996)

IgA pemphigus showing IgA antibodies to desmoglein 1 and 3
por: Hegazy, Salama, et al.
Publicado: (2016)

The Impact of IgA and the Microbiota on CNS Disease
por: Pu, Annie, et al.
Publicado: (2021)

α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
por: Smith, Lynnae M., et al.
Publicado: (2012)

IgA nephropathy in Brazil: apropos of 600 cases
por: Soares, Maria Fernanda, et al.
Publicado: (2015)

Relationship between Gd-IgA1 and TNFR1 in IgA nephropathy and IgA vasculitis nephritis in children – multicenter study
por: Mizerska-Wasiak, Małgorzata, et al.
Publicado: (2021)

Rabbit IgA Hinges That Resist IgA1 Protease Action Provide Options for Improved IgA-Based Therapeutic Agents
por: de Sousa-Pereira, Patrícia, et al.
Publicado: (2022)

Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
por: Tanaka, Mototsugu, et al.
Publicado: (2011)

Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
por: Berthelot, Laureline, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n87pm6tn7vrfj839f3n4rqdrtc